Frazier Life Sciences Acquisition II Closes $75 Million IPO
Frazier Life Sciences Acquisition II completed an IPO of 7.5 million Class A shares at $10.00 each and added a $25 million forward purchase backstop.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.